Rover Diagnostics
PrivateLast Round
Grant
Jul 15, 2024
Company Overview
Rover Diagnostics is a life sciences company that develops portable, point-of-care PCR diagnostic devices for the detection of infectious diseases.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Biotech Equipment, Precision Medicine, Biotechnology
Business Model
B2B
Customer Profile
Usage-Based SaaS, Hardware Sales
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Rover Diagnostics Comparables
Compare Rover Diagnostics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Nanopath | 83% | |
| Genomadix Inc. | 82% | |
| FluxErgy | 82% |
Rover Diagnostics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Jul 15, 2024 | ||||
| Grant | Oct 22, 2020 |
Rover Diagnostics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Columbia Technology Ventures | Seed |
| Harlem Biospace | Seed |
| National Institutes of Health (NIH) | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 25, 2026
Grew 23% QoQ, from 13 to 16 employees.
- Apr 25, 2026
Grew 21% QoQ, from 14 to 17 employees.
Rover Diagnostics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Rover Diagnostics's valuation, stock price, and market status.
Is Rover Diagnostics a public or private company?
Rover Diagnostics is a private company.
What is the current stock price of Rover Diagnostics?
Rover Diagnostics is a private company, so its shares have no public market price. Caplight tracks Rover Diagnostics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Rover Diagnostics worth (valuation)?
Valuation information for Rover Diagnostics is not publicly available.
Can I buy Rover Diagnostics stock?
Rover Diagnostics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Rover Diagnostics's last funding round?
Rover Diagnostics's most recent funding round was Grant on July 15, 2024.
Who are the main investors in Rover Diagnostics?
Key investors in Rover Diagnostics include Columbia Technology Ventures, Harlem Biospace, National Institutes of Health (NIH).
Will Rover Diagnostics IPO soon?
No public IPO plans have been announced for Rover Diagnostics.
How can I track Rover Diagnostics secondary market activity?
Caplight tracks bids, offers, and trades in Rover Diagnostics's shares on secondary markets.